摘要 |
A novel arylthiadiazole derivative represented by general formula (I) and useful for preventive or therapeutic treatment of human viral infection, or salts thereof, and an antiviral agent containing the same, wherein R<1>, R<2> and R<3> represent each hydrogen, halogeno, C1-C6 alkyl, trifluoromethyl, C1-C4 alkoxy, hydroxy, nitro, etc.; A represents (a), (b), (c), etc.; Y<1> represents oxygen or sulfur; W represents oxygen or sulfur; R<4> and R<5> represent each hydrogen; C1-C4 alkoxy, etc.; R<9> and R<10> represent each hydrogen or C1-C6 alkyl; R<14> represents hydrogen, C1-C6 alkyl, etc.; and n represents 0 or 1.
|
申请人 |
RATIONAL DRUG DESIGN LABORATORIES;IJICHI, KATSUSHI;SHIGETA, SHIRO;BABA, MASANORI;FUJIWARA, MASATOSHI;YOKOTA, TOMOYUKI;TAKAYAMA, HIROMITSU;SAKAI, SHIN-ICHIRO;HANASAKI, YASUAKI;IDE, TERUHIKO;WATANABE, HIROYUKI;KATSUURA, KIMIO |
发明人 |
IJICHI, KATSUSHI;SHIGETA, SHIRO;BABA, MASANORI;FUJIWARA, MASATOSHI;YOKOTA, TOMOYUKI;TAKAYAMA, HIROMITSU;SAKAI, SHIN-ICHIRO;HANASAKI, YASUAKI;IDE, TERUHIKO;WATANABE, HIROYUKI;KATSUURA, KIMIO |